We are pleased to announce our participation in the H.F.R.I. (Hellenic Foundation for Research and Innovation)-funded research project
“Advancing Personalized Radiotherapy through Biomarker-Guided Treatment and Personal Biological Dosimetry (APRBioDose)”. The project focuses on developing innovative approaches for personalized radiotherapy by integrating biological dosimetry, molecular biomarkers, and advanced computational models. Its goal is to optimize cancer treatment by tailoring radiation therapy to the individual characteristics of each patient, improving treatment outcomes while minimizing side effects.

Stay tuned for upcoming results and developments.